Fig. 1From: Abiraterone acetate in metastatic castration-resistant prostate cancer – the unanticipated real-world clinical experienceThe overall survival for mCRPC patients with (post-chemo) or without prior chemotherapy (chemo-naïve) treated with AABack to article page